Compare Liberty Global Ltd Class C (LBTYK) vs McKesson Corporation (MCK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Liberty Global Ltd Class C vs McKesson Corporation — how do they compare? Liberty Global Ltd Class C trades at $8.52 (market cap $3.06B), while McKesson Corporation trades at $938.84 (market cap $108.46B). The key difference: McKesson Corporation is far larger — about 35.4× Liberty Global Ltd Class C's market cap, and McKesson Corporation pays a 0.4% dividend while Liberty Global Ltd Class C pays none. Which is the better fit depends on your goals — on Pluang, investors hold Liberty Global Ltd Class C for 21 Days and McKesson Corporation for 74 Days on average.
| LBTYK | MCK | |
|---|---|---|
Market Cap | $3.06B | $108.46B |
Volume | 2,508,956 | 712,607 |
Sector | Media | Health |
52-Week High | $12.67 | $995.69 |
52-Week Low | $8.52 | $725.17 |
Typical Hold Time | 21 Days | 74 Days |
Enterprise Value | $9.72B | $115.00B |
Dividend Yield | — | 0.4% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
LBTYK trades at $8.75, near its 52-week low, reflecting a bearish technical trend with weak moving averages and oscillators. Fundamentally, the company reported a net loss of -$7.14B in 2025 despite $4.88B in revenue, though 2026 shows improvement with a reduced loss of -$3.0B. Recent strategic moves include the Ziggo Group spin-off preparation and an AI partnership to enhance customer experience.
The stock presents a high-risk opportunity with a discounted valuation (P/S 0.61, P/B 0.32) and strong analyst support (69% buy ratings, $12.67 target). Key risks are persistent losses and execution challenges, but upside potential exists if Ziggo's 2027 listing and cost controls drive profitability.
McKesson (MCK) trades at $930.25, up 2.19% today, with a bullish technical outlook and strong analyst support. The stock shows consistent earnings beats, with Q2 2026 EPS of $9.93 surpassing the $9.56 estimate. Revenue growth is robust, reaching $359.05B in 2025, though net margins are thin at 1.12%. Recent news highlights a key distribution extension with CVS Health through 2032, reinforcing long-term visibility.
The outlook is positive, driven by operational strength and strategic partnerships, but investors face risks from margin pressure and drug pricing uncertainty. With 81% of analysts rating it Buy and a consensus target of $956.43, the stock offers upside, though high RSI levels suggest near-term caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Liberty Global Ltd Class C
Liberty Global is a world leader in converged broadband, video, and mobile communications. It operates large-scale fiber and 5G networks across Europe, providing essential digital services to millions of customers.
Read more on LBTYK →About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →
